Cited by 683Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Tau protein pathology in neurodegenerative diseases

Spillantini, Maria Grazia, Goedert, Michel·1998·Trends in Neurosciences

Abstract

Abundant tau-positive neurofibrillary lesions constitute a defining neuropathological characteristic of Alzheimer's disease. Filamentous tau pathology is also central to a number of other dementing disorders, such as Pick's disease, progressive supranuclear palsy, corticobasal degeneration and familial frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). The discovery of mutations in the tau gene in FTDP-17 has firmly established the relevance of tau pathology for the neurodegenerative process. Experimental studies have provided a system for the assembly of full-length tau into Alzheimer-like filaments, providing an assay for the testing of compounds that inhabit the formation of tau filaments.

Integrity signals

Registry

Crossref · 10.1016/s0166-2236(98)01337-x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Spillantini, M. G., & Goedert, M.
Affiliations
  • University of Cambridge (GB)
  • MRC Laboratory of Molecular Biology (GB)
Venue
Trends in Neurosciences
Publisher
Elsevier BV
Published
1998-10
Volume
21
Issue
10
Pages
428-433
ISSN
0166-2236 (ISSN-L)
OpenAlex
W2035282018
Cited by
683
References
6
Citations by year
2026: 5 · 2025: 16 · 2024: 16 · 2023: 12 · 2022: 18 · 2021: 23 · 2020: 23 · 2019: 18 · 2018: 15 · 2017: 15 · 2016: 19 · 2015: 16 · 2014: 15 · 2013: 22 · 2012: 27
FWCI
8.11
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Neurosciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
tau protein, neurofibrillary tangles, Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, FTDP-17, tau gene mutations, tau aggregation inhibitors, neurodegenerative diseases
MeSH terms
Alzheimer Disease, Brain, Chromosomes, Human, Pair 17, Dementia, Female, Humans, Male, Neurofibrils, Protein Biosynthesis, Neurofibrillary Tangles, tau Proteins, Point Mutation, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review